Toronto - Delayed Quote CAD

Hamilton Thorne Ltd. (HTL.TO)

Compare
2.2500 +0.0100 (+0.45%)
At close: November 18 at 3:59 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Mr. David B. Wolf Executive Chairman 632.31k -- --
Mr. Francesco Fragasso CPA Chief Financial Officer 535.44k -- --
Mr. Justin Jaundoo Vice President of Corporate Development 371.71k -- --
Mr. Brett M. Fulton Senior VP & GM of HT Inc. 425.39k -- --
Dr. Julia Heinzmann Managing Director of Gynemed, GmbH & Co KG 282.2k -- --
Dr. Ekaterina Torchilin MBA, Ph.D. President, CEO & Director -- -- --
Mr. Thomas Kenny Senior Vice President Global Operations & Sustaining Engineering and Management Rep 216.55k -- --
Ms. Kimberly Marolda Director of HR -- -- --
Mr. Eric V. Dorman President of Embryotech Laboratories Inc -- -- --
Dr. Fabian Sell Chief Executive Officer of Gynemed 379.95k -- --

Hamilton Thorne Ltd.

100 Cummings Centre
Suite 465E
Beverly, MA 01915
United States
800 323 0503 https://www.hamiltonthorne.ltd
Sector:?
Healthcare
Industry:?
Medical Devices

Description

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

Corporate Governance

Hamilton Thorne Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 14, 2024 at 12:59 PM UTC

Hamilton Thorne Ltd. Earnings Date

Recent Events

Related Tickers